v3.26.1
ACQUISITIONS
 6 Months Ended
Jun. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
ACQUISITIONS ACQUISITIONS
Business Combinations
The Company has determined that the acquisitions discussed below are considered business combinations under ASC Topic 805, Business Combinations, and are accounted for by applying the acquisition method, whereby the assets acquired and the liabilities assumed are recorded at their fair values with any excess of the aggregate consideration over the fair values of the identifiable net assets allocated to goodwill. Operating results are included in these Financial Statements from the date of the acquisition.
The purchase price allocation for each acquisition reflects various preliminary fair value estimates and analyses, including certain tangible assets acquired and liabilities assumed, the valuation of intangible assets acquired, and goodwill, which are subject to change within the measurement period as preliminary valuations are finalized (generally one year from the acquisition date). Measurement period adjustments are recorded in the reporting period in which the estimates are finalized and adjustment amounts are determined.
2026 Acquisitions
Northeast Partnership Dispensaries Seven and Eight
In April 2026, Northeast Retail Partner Seven (as defined in Note 8, “Variable Interest Entities”) entered into a definitive agreement to acquire two adult-use dispensaries (“Northeast Partnership Dispensaries Seven and Eight”), which agreement is subject to regulatory approval. The parties also entered into a consulting agreement under which Northeast Retail Partner Seven will provide management and advisory services for a set fee. This consulting agreement became effective in April 2026 and will remain in place until regulatory approval of the definitive agreement is received and the underlying transaction thereby closes. Based on the provisions of this consulting agreement, Northeast Retail Partner Seven obtained operational and financial influence over Northeast Partnership Dispensaries Seven and Eight and therefore recognized the transaction as a business combination as of the April 2026 effective date of the consulting agreement. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs. Total cash consideration for Northeast Partnership Dispensaries Seven and Eight is $3,600, of which $800 was remitted in May 2026 and the remainder is due at final closing, subject to customary closing adjustments, as applicable.
Midwest Partnership Two Dispensaries
In May 2026, Midwest Retail Partner Two, as described in Note 8, “Variable Interest Entities,” entered into a definitive agreement to acquire four adult-use dispensaries (the “Midwest Partnership Two Dispensaries”), which agreement is subject to regulatory approval. The parties also entered into a management services agreement (“MSA”) pursuant to which Midwest Retail Partner Two will provide certain management and advisory services for a set fee. This MSA became effective in May 2026, following regulatory approval of the MSA, and will remain in place until the definitive agreement receives regulatory approval and the underlying transaction closes. Based on the provisions of this MSA, Midwest Retail Partner Two obtained operational and financial influence over the Midwest Partnership Two Dispensaries and therefore recognized the transaction as a business combination as of May 2026. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs.
The total consideration for the Midwest Partnership Two Dispensaries was determined to have an estimated fair value of $22,300. Of the total consideration, a deposit of $3,200 was remitted during the three months ended March 31, 2026 and $2,500 was remitted during the three months ended June 30, 2026. The remaining stated cash consideration of $18,800 is due at final closing, subject to certain customary adjustments (the “Midwest Partnership Two Dispensaries Sellers’ Note”). The Midwest Partnership Two Dispensaries Sellers’ Note was initially recorded net of a discount of $2,200 based on an anticipated payment date utilizing the Company’s incremental borrowing rate; refer to Note 11, “Debt,” for additional information.
Preliminary Purchase Price Allocations
The following table summarizes the preliminary purchase price allocations for the business combinations recognized in 2026, described above, which remain preliminary as management refines certain estimates during the respective measurement periods:
(in thousands)
Northeast Partnership Dispensaries Seven and Eight
Midwest Partnership Two Dispensaries
Assets acquired (liabilities assumed):
Cash$14 $34 
Inventory358 831 
Other current assets
79 209 
Property and equipment(1)
743 2,714 
Other assets122 491 
License(2)
1,570 11,720 
Goodwill(3)
714 6,301 
Net assets acquired
$3,600 $22,300 
Consideration transferred:
Cash(4)
$3,600 $22,300 
Total consideration
$3,600 $22,300 
(1)Consists of $706 of leasehold improvements and $37 of furniture, fixtures, and equipment related to Northeast Partnership Dispensaries Seven and Eight and $2,610 of leasehold improvements and $104 of furniture, fixtures, and equipment related to the Midwest Partnership Two Dispensaries.
(2)The amortization period for the acquired licenses is 10 years.
(3)Goodwill is largely attributable to the value expected to be obtained from long-term business growth and buyer-specific synergies. Goodwill is largely not deductible for tax purposes under the limitations under Internal Revenue Code (“IRC”) Section 280E; see Note 14, “Income Taxes,” for additional information.
(4)Of the total cash consideration, $800 was paid in May 2026 for Northeast Partnership Dispensaries Seven and Eight. A deposit of $3,200 was remitted during the three months ended March 31, 2026 and $2,500 was remitted during the three months ended June 30, 2026 related to the Midwest Partnership Two Dispensaries. The remaining consideration due for each transaction is included within sellers’ notes as a component of debt; refer to Note 11, “Debt,” for additional information.
The consolidated entities also agreed to assume the lease for the associated locations for each of the transactions described above and recognized a total finance lease liability and ROU asset of $2,121 related to Northeast Partnership Dispensaries Seven and Eight and $4,989 related to the Midwest Partnership Two Dispensaries. Direct transaction costs associated with these transactions were not material.
Pro forma financial information is not presented for these acquisitions, as such results are immaterial, individually and in aggregate, to both the current and prior periods. The Company’s consolidated results of operations for each of the three and six months ended June 30, 2026 includes $3,555 of revenue and $154 of net loss, combined, related to these transactions from the respective acquisition dates.
2025 Acquisitions
Midwest Partnership Dispensary Three
In January 2025, a consolidated VIE of the Company (Midwest Retail Partner One, as defined in Note 8, “Variable Interest Entities”) entered into a definitive agreement to acquire an entity that owns and operates an adult-use dispensary (“Midwest Partnership Dispensary Three”), which agreement was subject to regulatory approval. The parties also entered into an MSA pursuant to which Midwest Retail Partner One will provide certain management and advisory services for a set fee. This MSA became effective in March 2025, following its regulatory approval. Based on the provisions of this MSA, Midwest Retail Partner One obtained operational and financial influence over Midwest Partnership Dispensary Three and therefore recognized the transaction as a business combination as of the March 2025 regulatory approval date of this MSA. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs. This MSA remained in place until final closing of the underlying transaction that occurred in April 2026.
Total anticipated cash consideration for the Midwest Partnership Dispensary Three transaction was $1,667, of which $833 was paid upon the regulatory approval of the MSA and the remainder was due at final closing, subject to certain closing adjustments. During the six months ended June 30, 2026, the parties agreed to reduce consideration by $18, which was reflected as a final measurement period adjustment to accounts payable and accrued liabilities, and the final closing payment was paid at closing in April 2026. This agreement also provides for an earn-out payment, to be paid in cash, based on 3.2-times EBITDA (as defined in the underlying agreement) that is achieved during a specified twelve-month period, less the purchase price. The initial fair value estimate of $1,600 for this earn-out was determined utilizing an income approach based on a probability-weighted estimate of the future payment discounted using the Company’s estimated incremental borrowing rate and is classified within Level 3 of the fair value hierarchy. As of June 30, 2026, the estimated fair value of this earn-out was reduced to zero based on the underlying metrics. The estimated fair value was $1,250 as of December 31, 2025 and was included within “Accounts payable and accrued liabilities” on the unaudited Condensed Consolidated Balance Sheet as of that date. A change in estimated fair value of $900 and $1,250 was recognized during the three and six months ended June 30, 2026, respectively, and is included within “General and administrative expenses” on the unaudited Condensed Consolidated Statements of Operations.
Midwest Partnership Dispensary Four
In January 2025, Midwest Retail Partner One entered into a definitive agreement to acquire an entity that owns and operates an adult-use dispensary (“Midwest Partnership Dispensary Four”), which agreement was subject to regulatory approval. The parties also entered into an MSA pursuant to which Midwest Retail Partner One will provide management and advisory services for a set fee. This MSA became effective in May 2025, following its regulatory approval. Based on the provisions of this MSA, the Midwest Retail Partner One obtained operational and financial influence over Midwest Partnership Dispensary Four and therefore recognized the transaction as a business combination as of the May 2025 regulatory approval date of this MSA. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs. This MSA remained in place until final closing of the underlying transaction that occurred in April 2026.
Total cash consideration for the Midwest Partnership Dispensary Four transaction was $3,333, of which $1,667 was paid upon the regulatory approval of the MSA and the remainder was due at final closing, subject to certain closing adjustments. During the six months ended June 30, 2026, the parties agreed to reduce consideration by $174, which included a measurement period adjustment of $74 related to accounts payable and accrued liabilities and the remainder to goodwill, and the final closing payment was paid at closing in April 2026. This agreement also provides for an earn-out payment, to be paid in cash, based on 3.2-times EBITDA (as defined in the underlying agreement) that is achieved during a specified twelve-month period, less the purchase price. The initial fair value estimate of $1,900 for this earn-out was determined utilizing an income approach based on a probability-weighted estimate of the future payment discounted using the Company’s estimated incremental borrowing rate and is classified within Level 3 of the fair value hierarchy. As of June 30, 2026, the estimated fair value was reduced to zero based on the underlying metrics. As of December 31, 2025, the estimated fair value of this earn-out was $1,540 and was included within “Accounts payable and accrued liabilities” on the unaudited Condensed Consolidated Balance Sheet as of that date. A change in estimated fair value of $1,400 and $1,540 was recognized during the three and six months ended June 30, 2026, respectively, and is included within “General and administrative expenses” on the unaudited Condensed Consolidated Statements of Operations.
Northeast Partnership Dispensary One
In May 2025, Northeast Retail Partner Three (as defined in Note 8, “Variable Interest Entities”) entered into a definitive agreement to acquire an adult-use dispensary (the “Northeast Partnership Dispensary One”). The parties also entered into a consulting agreement under which Northeast Retail Partner Three provided management and advisory services for a set fee while the transaction was pending final closing. The transaction was recognized as a business combination as of the June 2025 effective date of the consulting agreement. Total cash consideration for Northeast Partnership Dispensary One was $3,250, of which $813 was paid at signing and the remainder was paid at final closing, which occurred in December 2025. Closing adjustments were not material. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs.
Northeast Partnership Dispensaries Two and Three
In September 2025, Northeast Retail Partner Three (as defined in Note 8, “Variable Interest Entities”) acquired an entity that owns and operates two adult-use dispensaries (“Northeast Partnership Dispensaries Two and Three”), which transaction was completed pursuant to a definitive agreement that was signed in February 2025 and was subject to certain closing conditions, including regulatory approval of the underlying transaction which was received prior to closing. The stated purchase price consisted of $7,850 of cash consideration, subject to certain working capital and other customary adjustments, and of which $250 was paid as a deposit at signing. Total cash consideration included the settlement of $4,779 related to an outstanding note with a principal balance of $4,100 and associated interest. As of the closing date, the Company paid $1,541, which included an initial working capital estimate of $1,040. In December 2025, the parties agreed to a revised working capital estimate that reduced this estimate by $2,609. The resulting net estimate of $289 is included within “Other current assets” on the unaudited Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025. The final working capital adjustment and any resulting payment is due on the one-year anniversary of closing.
This transaction also provides for an earn-out payment, payable in cash, in an amount equal to the lesser of $2,000 or three times the Annual EBITDA (as defined in the underlying agreement) during the one-year period following closing. The initial fair value estimate of $1,800 for this earn-out was determined utilizing an income approach based on a probability-weighted estimate of the future payment discounted using the Company’s estimated incremental borrowing rate and is classified within Level 3 of the fair value hierarchy. As of June 30, 2026, the estimated fair value of this earn-out was reduced to zero based on the underlying metrics. The estimated fair value was $1,823 as of December 31, 2025 and was included within “Accounts payable and accrued liabilities” on the unaudited Condensed Consolidated Balance Sheet as of that date. A change in estimated fair value of $1,881 and $1,823 was recognized during the three and six months ended June 30, 2026, respectively, and is included within “General and administrative expenses” on the unaudited Condensed Consolidated Statements of Operations. No material measurement period adjustments to the purchase price allocation were reflected during the six months ended June 30, 2026.
Financial and Pro Forma Information
The following table summarizes the revenue and net income (loss) related to the acquisitions that were consolidated during 2025, as described above, from their respective effective dates, as applicable. Pro forma financial information is not presented for these acquisitions, as such results are immaterial, individually and in aggregate, to both the current and prior periods.
Three Months Ended
June 30, 2026		Three Months Ended
June 30, 2025
(in thousands)Revenue
Net income (loss)
Revenue
Net loss
Midwest Partnership Dispensary Three
$1,060 $90 $827 $(196)
Midwest Partnership Dispensary Four
1,862 386 251 (72)
Northeast Partnership Dispensary One
1,458 295 425 (24)
Northeast Partnership Dispensaries Two and Three
2,341 (333)— — 
Six Months Ended
June 30, 2026		Six Months Ended
June 30, 2025
(in thousands)Revenue
Net income (loss)
Revenue
Net loss
Midwest Partnership Dispensary Three
$2,081 $488 $902 $(184)
Midwest Partnership Dispensary Four
3,454 739 251 (72)
Northeast Partnership Dispensary One
2,783 373 425 (24)
Northeast Partnership Dispensaries Two and Three
4,558 (795)— — 
2024 Acquisition
Effective in April 2024, Midwest Retail Partner One acquired two dispensaries in the greater Chicago, Illinois area (the “2024 Midwest Partner Dispensaries”). The parties also entered into interim MSAs pursuant to which Midwest Retail Partner One will advise on certain business, operational, and financial matters for a monthly fee while the parties finalize asset purchase agreements to acquire the underlying dispensaries (the “2024 Midwest MSAs”). Based on the provisions of the 2024 Midwest MSAs, the third party obtained operational and financial influence over the dispensaries and therefore recognized the transaction as a business combination as of the April 2024 regulatory approval date of the 2024 Midwest MSAs. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs.
The stated total purchase price was approximately $10,000 of cash consideration, subject to certain closing adjustments. An initial deposit of $1,500 was remitted during the first quarter of 2024 and the remainder of $8,500 was remitted to escrow during the second quarter of 2024. In November 2025, the parties agreed to reduce the purchase price by $1,250, which funds were received from escrow, and $5,750 was released to the sellers at that time. The balance of the revised purchase price remained in escrow as of June 30, 2026, to be released upon final closing, subject to certain closing adjustments. Final closing of the asset purchase agreements in respect of the 2024 Midwest Partner Dispensaries remains subject to regulatory approval.
Asset Acquisitions
The Company determined the acquisitions below did not meet the definition of a business and are therefore accounted for as asset acquisitions. When the Company acquires assets and liabilities that do not constitute a business or VIE of which the Company is the primary beneficiary, the cost of each acquisition, including certain transaction costs, is allocated to the assets acquired and liabilities assumed on a relative fair value basis. Contingent consideration associated with the acquisition is generally recognized only when the contingency is resolved.
When the Company acquires assets and liabilities that do not constitute a business but meet the definition of a VIE of which the Company is the primary beneficiary, the purchase is accounted for using the acquisition method described above for business combinations, except that no goodwill is recognized. To the extent there is a difference between the purchase consideration, including the estimated fair value of contingent consideration, plus the estimated fair value of any non-controlling interest and the VIE’s identifiable assets and liabilities recorded and measured at fair value, the difference is recognized as a gain or loss. A non-controlling interest represents the non-affiliated equity interest in the underlying entity. Transaction costs are expensed.
2026 Asset Acquisition
Northeast Retail Partnership Dispensary Six
In April 2025, the Company entered into a definitive agreement pursuant to which the Company proposed to acquire an entity that anticipated obtaining an adult-use license (“Northeast Retail Partnership Dispensary Six”) and receive $1,000 of cash consideration in exchange for the Company’s Ohio cultivation license (the “Ohio Cultivation License”). This transaction was subject to certain closing conditions, including regulatory approvals, and closed in March 2026. Northeast Retail Partnership Dispensary Six was not operational at the time of closing and therefore the Company accounted for this transaction as an asset acquisition and allocated the cost of $2,700 to the license acquired, in addition to an acquisition-related deferred tax liability of $1,063. The cost of the transaction was measured by the fair value of the non-cash consideration received in the transaction, which was estimated based on a discounted cash flow model utilizing inputs primarily classified within Level 3 of the fair value hierarchy plus the fair value of the cash received. The Company recognized a gain on sale of $137, which is included within “General and administrative expenses” for the six months ended June 30, 2026. This gain represented the excess of fair value compared with the $3,529 book value of the Ohio Cultivation License, less the $1,000 cash received and a nominal value associated with inventory. The Ohio Cultivation License was de-recognized as of the transaction date; refer to Note 9, “Intangible Assets and Goodwill,” for additional information. The parties also settled $349 that the Company previously funded under a note receivable and reimbursed the seller for an additional $588 related to capital expenditures. The Company also assumed the lease for the dispensary location which had a lease liability and ROU asset of $1,066 as of the effective date and is classified as an operating lease; refer to Note 10, “Leases,” for additional information regarding the Company’s leases. Transaction costs were not material. This transaction was with a specific buyer and the Company determined the Ohio Cultivation License did not meet the criteria to be classified as held-for-sale as of December 31, 2025.
2025 Asset Acquisitions
In December 2024, Midwest Retail Partner One entered into a definitive agreement to acquire the membership interests of an entity that anticipates receiving two adult-use licenses, which agreement is subject to regulatory approval. In conjunction with this definitive agreement, the parties entered into certain MSAs under which Midwest Retail Partner One will provide certain management and advisory services for a set fee. Based on the provisions of the agreements, Midwest Retail Partner One obtained operational and financial influence over the underlying entity and therefore recognized the transaction as an asset acquisition as of the February 2025 regulatory approval date of these MSAs. Total cash consideration for this transaction may be up to $4,000, subject to certain closing adjustments, and was allocated to the licenses acquired as of the effective date, in addition to an acquisition-related deferred tax liability of $1,755. Of the total consideration, $1,000 was paid at signing in December 2024. A total of up to $1,500 is expected to be paid upon opening of the associated dispensary locations and a total of up to $1,500 is expected to be paid upon final closing of the associated transaction. One of the dispensary locations opened in March 2026, and a payment of $750 was made in May 2026 in accordance with the agreement. The total of these expected payments, less payments made, is included as a sellers’ note as of June 30, 2026 and December 31, 2025, as applicable; refer to Note 11, “Debt.” Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs, including Midwest Retail Partner One.
In January 2025, Midwest Retail Partner One entered into a definitive agreement to acquire a conditional adult-use license, which agreement is subject to regulatory approval. In conjunction with this definitive agreement, the parties entered into certain MSAs under which Midwest Retail Partner One will provide certain management and advisory services for a set fee. The parties also entered into a working capital loan and security agreement, under which Midwest Retail Partner One could loan up to $3,650 for the build-out of the associated dispensary. Based on the provisions of the MSAs and working capital loan, Midwest Retail Partner One obtained operational and financial influence over the underlying assets as of the February 2025 regulatory approval date of the MSAs. As such, this transaction was accounted for as an asset acquisition as of that date and the total consideration was allocated as the cost of the license acquired. In October 2025, the parties amended the definitive agreement to, among other provisions, reduce the $1,900 of total cash consideration by $150 and advance $450 at that time. The associated dispensary opened in May 2025 and final closing of the underlying transaction occurred in July 2026. At closing, the remaining $1,300 of cash consideration was paid and the working capital loan was forgiven. The closing payment was included as a sellers’ note as of June 30, 2026 and December 31, 2025. Direct transaction costs were not material. Refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs, including the Midwest Retail Partner One.
In August 2025, the Company acquired a conditional adult-use license for $2,000 of cash consideration. This transaction (“Northeast Retail Partnership Dispensary Five”) was accounted for as an asset acquisition as of the effective date and the total cash consideration was allocated as the cost of the license acquired, in addition to an acquisition-related deferred tax liability of $878. Of the total cash consideration, $1,000 was paid to the seller as of the effective date and the remainder was remitted to escrow and was released to the sellers in April 2026. Regulatory approval of the underlying license transfer remains pending. The Company also assumed the lease for the associated dispensary location; refer to Note 10, “Leases,” for additional information regarding the Company’s leases. Direct transaction costs were not material.
Previous Asset Acquisitions
Ohio Patient Access
As previously disclosed, on August 12, 2022, the Company entered into a definitive agreement (the “Ohio Agreement”) that provided the Company the option to acquire 100% of the equity of Ohio Patient Access LLC (“OPA”), the holder of a license that grants it the right to operate three medical dispensaries in Ohio. Under the Ohio Agreement, the Company would also acquire the real property of the three dispensary locations. The Ohio Agreement was subject to regulatory review and approval and, once received, the Company could exercise the option, the exercise of which was solely within the Company’s control. In June 2024, the Ohio Agreement was amended to, among other provisions, extend the option exercise period to March 22, 2026 and to also incorporate certain provisions regarding evolving regulations in Ohio, including that the Company will receive two additional adult-use licenses that are expected to be awarded to OPA.
In July 2025, the Company entered into certain amendments related to the Ohio Agreement that, among other provisions, permitted the Company to acquire the real property of the dispensary locations in advance of the license ownership transfer and advanced to the sellers $2,000 of the remaining $11,000 of cash consideration that was due at final closing (the “OPA Sellers’ Note”). Effective on August 5, 2025, the Company acquired the entity that holds the real property. In September 2025, the Company notified the sellers that it was exercising the option to acquire OPA. The related transaction closed in October 2025 and $7,000 of the OPA Sellers’ Note was paid at that time. The remaining $2,000 of total transaction consideration is included as a sellers’ note as of June 30, 2026 and December 31, 2025 (refer to Note 11, “Debt”) and will be remitted upon the final regulatory approval of the transfer of each of the two additional licenses, which the Company anticipates may occur within twelve months after each of the dispensary locations open. One of the locations opened in January 2026 and the second is expected to open by the end of 2026, subject to certain approvals.
In conjunction with the Ohio Agreement, the parties entered into a support services agreement under which the Company would provide management and advisory services to OPA for a set monthly fee until such time as the underlying transaction closes and the parties also entered into a working capital loan agreement under which the Company may, at its full discretion, loan OPA funds for general working capital needs. The Company determined OPA was a VIE and the Company became the primary beneficiary as of the signing date; therefore, OPA was consolidated as a VIE as of the initial signing date through the October 2025 closing date; refer to Note 8, “Variable Interest Entities,” for additional information regarding the Company’s VIEs.